James Healy, Director at ArriVent Biopharma, Inc. (AVBP), bought 1,696,752 shares at $18.00 ($8.0M) on 2024-01-30, disclosed to the SEC on 2024-01-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,252,308 | $0 | 0.0% |
| 2 | $18.00 | 444,444 | $8.0M | 100.0% |
| Total | $4.71 avg | 1,696,752 | $8.0M | 100% |
| Filing → |
| RAPP | BUY | 2024-06-10 | $9.5M | — | Filing → |
| NTRA | SELL | 2023-12-22 | $37.8M | — | Filing → |
| CINC | SELL | 2023-02-27 | $86K | — | Filing → |